Cardiovascular disease is the #1 cause of death in the developed world, and it is rapidly overtaking other causes of premature death and suffering in less developed countries. Only a handful of academic centers are capable of making the contributions required to prevent this anticipated growth. Johns Hopkins is among this very elite group, and our team members are committed to engineering a future without cardiovascular disease.
We are in the process of reenvisioning our Heart and Vascular Institute. It will expand to better embrace all the hospitals and ambulatory clinics across our health system, allowing all of our faculty and staff to access a more integrated data repository to improve processes, answer research questions and personalize therapies.
Our program has outstanding strengths in cardiovascular disease prevention. And our faculty focuses on advanced therapies, including transplant, percutaneous and surgical repair of heart and blood vessels, cardiac imaging, and therapies performed in the cardiac and surgical intensive care units and the Electrophysiology and Arrhythmia Service. We are immensely proud of our collaborations with the Whiting School of Engineering, the Bloomberg School of Public Health, basic science departments in the school of medicine, and the Johns Hopkins Applied Physics Laboratory.
We also envision three new programs with enhanced capacity for discovery related to heart failure, atrial fibrillation and atherosclerotic vascular disease. Key discoveries at Johns Hopkins will unlock this knowledge to provide new and more effective cures and personalized preventive strategies.
We are excited to begin our future now, and we are grateful for your support.